Skip to main content
The British Journal of General Practice logoLink to The British Journal of General Practice
. 2011 Apr 26;61(586):e244–e251. doi: 10.3399/bjgp11X572436

Impact on antibiotic prescription of rapid antigen detection testing in acute pharyngitis in adults: a randomised clinical trial

Carl Llor 1,2,3,4,5, Jordi Madurell 1,2,3,4,5, Montse Balagué-Corbella 1,2,3,4,5, Mónica Gómez 1,2,3,4,5, Josep Maria Cots 1,2,3,4,5
PMCID: PMC3080229  PMID: 21619748

Abstract

Background

Acute pharyngitis is one of the most frequent reasons for a GP consultation, and in most cases an antibiotic is prescribed.

Aim

To determine the impact of rapid antigen detection testing (RADT) to identify group A beta haemolytic streptococcus in acute pharyngitis on the utilisation of antibiotics and appropriateness of their use.

Design and setting

Cluster randomised controlled trial in primary care centres in Catalonia, Spain.

Method

Patients with acute pharyngitis aged 14 years or older with at least one Centor criterion (fever, tonsillar exudate, tender enlarged anterior cervical lymph nodes, or absence of cough) were recruited. Participant physicians were randomly assigned to one of two study arms: an intervention group (assigned to RADT) and a control group (following usual care, without RADT).

Results

Of the 557 adults enrolled, 543 could be evaluated for analysis (281 [51.7%] in the intervention group and 262 [48.3%] in the control group). GPs without access to RADT were more likely to prescribe antibiotics compared with those who performed rapid tests (64.1% versus 43.8%, P<0.001). The more Centor criteria the patients presented, the greater the number of antibiotics prescribed, regardless of whether RADT was available (P<0.001). Antibiotics were prescribed in 30.7% of the cases with negative RADT results. Inappropriate antibiotic prescription was observed in 226 cases (43%), and was significantly greater in the control than in the intervention group (60% versus 26.9%; P<0.001).

Conclusion

Even though more than 30% of negative RADT results resulted in antibiotic prescribing, the study findings support the use of RADT in the consultation. This strategy has an important impact on reducing antibiotic prescription among adults with acute pharyngitis.

Keywords: criteria, clinical; clinical trials, randomised; rapid antigen detection test; primary care; Streptococcus; Streptococcus Group A


How this fits in

This is a clinical trial comparing the proportion of antibiotic prescription and the inappropriateness of this prescription for suspected acute pharynigitis among two groups of physicians: GPs in one group were provided with rapid antigen detection tests as a guide for prescribing antibiotics in adults and at least one clinical criterion of streptococcal aetiology; GPs in the second group followed their usual clinical practice, without the use of these tests, to decide whether treatment should include antibiotics. Results of the study demonstrate that the intervention was effective in significantly decreasing antibiotic prescription by more than 20% and in reducing the inappropriateness of prescription by 33%. However, this reduction would probably have been greater if physicians who were randomly assigned to the intervention group had trusted the results of these rapid tests, indicating that training aimed at physicians who have never used these tests is essential.

INTRODUCTION

Acute pharyngitis is a frequent cause of visits and antibiotic prescribing in the primary care setting. It has been estimated that 52% to 89% of adults with acute pharyngitis are treated with antibiotics.17 However, group A beta haemolytic streptococcus (GABHS) is the cause in only 10–30% of the cases of acute pharyngitis, and is even less frequent in adults, accounting for 10–15% of all the infections.7,8 The majority of authors recommend the use of antibiotics for streptococcal pharyngitis, as prompt antibiotic therapy is associated with a slightly faster recovery of symptoms, prevention of early and late complications, and reduced spread of the strain to others.9 In the UK, the National Institute for Health and Clinical Excellence (NICE) recommends that clinicians consider immediate treatment with antibiotics for patients who have three or more Centor criteria: fever, tonsillar exudate, tender enlarged anterior cervical lymph nodes and absence of cough.10 However, regardless of whether they receive treatment with antibiotics, 85% of patients with acute pharyngitis are completely free of symptoms after the first week.11 A study of patients with tonsillitis in 17 European countries found that the mean duration of fever was 2–3 days, irrespective of the use of an antibiotic.12 In addition, serious complications are uncommon nowadays.13,14

Overuse of antibiotics can lead to side effects and the emergence of antibiotic resistance.15 The main reason for antibiotic overprescription in acute pharyngitis is the difficulty of obtaining a rapid and correct aetiological diagnosis. In addition, physicians often believe that patients expect an antibiotic and, in case of doubt, GPs are more prone to prescribing antibiotics.

In many countries, including Spain, rapid antigen detection tests (RADTs) are seldom used in general practice and physicians still rely on the Centor criteria for prescribing antibiotic therapy.16 However, due to the fact that these findings are non-specific and are commonly found in cases of viral origin, even experienced physicians may accurately diagnose streptococcal pharyngitis based on the clinical findings alone in no more than 75% of the cases.17 In addition, primary care physicians evaluate each of the Centor criteria differently. Thus, in Spain, physicians are 28-fold more inclined to prescribe an antibiotic in acute pharyngitis when this is accompanied by tonsillar exudates.2 Moreover, in the different clinical trials carried out, the use of sore throat decision rules based only on clinical criteria have not been shown to be useful in reducing the prescription of antibiotics.1820

Culture of a throat swab has been the standard method for diagnosing streptococcal pharyngitis. However, the delay in obtaining results makes its performance useless in clinical practice. Over recent years, low-cost and rapid immunological techniques targeting the detection of GABHS antigens have been developed for use in the clinical setting. These tests offer the advantage of diagnosing streptococcal pharyngitis within a few minutes, with an associated specificity of more than 95% and a sensitivity ranging from 60% to 96%, using culture as the gold standard method.21,22 Several papers have shown that the use of these tests can reduce the prescription of antibiotics for pharyngitis in children. However, very few studies have examined the impact of RADT on the pattern of how GPs prescribe antibiotics for adult patients with pharyngitis.20,23,24 This randomised clinical trial was carried out to compare the percentage of antibiotic prescription and the inappropriateness of antibiotic prescription by GPs using RADT and GPs whose antibiotic prescription was only based on clinical criteria.

METHOD

The methodology of this study has been described in detail elsewhere.25 In brief, this was a cluster multicentre parallel randomised clinical trial carried out in 20 primary healthcare centres in Catalonia, Spain from January to May 2008. No blinding techniques were used. All physicians were asked to recruit consecutively the first 10 patients aged 14–60 years diagnosed with acute pharyngitis with one or more Centor criteria: fever, sore throat, tonsillar exudate, tender cervical nodes, and/or absence of cough. All patients were asked to provide written informed consent. Exclusion criteria were patients with more than five episodes of pharyngitis over the last year; those with immunosuppressed condition, such as active neoplasm, acquired immunodeficiency syndrome, or reception of chemotherapy, radiotherapy, steroids, and/or immunosuppressive therapy; those with heart valve disease; rheumatic fever; an episode of pharyngitis treated with antibiotics in the previous 15 days; and those who had tonsillectomy.

Participating primary healthcare centres were randomised to the intervention or to the control arm of the study, with an allocation ratio of 1:1, by a random sequence generated by a computer program. Physicians allocated to the intervention group were provided with RADT and those assigned to the control group managed streptococcal pharyngitis with only clinical criteria. Samples were taken by GPs who had been previously trained to perform the technique correctly with vigorous rotation of the tonsils and the posterior pharynx without touching the tongue, teeth, or gums. RADTs were undertaken with the OSOM® Strep A test (Genzyme) following the manufacturer's instructions. All physicians participating in this study sent a pharyngeal swab for culture. These samples were sent to the Department of Microbiology of the two hospitals of the area, with AMIES (Copan Innovation, Italy) as medium. Samples were seeded on a plate of blood agar and incubated at 37°C in an atmosphere of CO2 at 5% over 48 hours. A culture was considered positive for GABHS with a growth of any number of beta-haemolytic colonies, Gram staining with streptococcal morphology, and a catalase-negative test with posterior identification with an automated panel for WIDER Gram-positive cocci (Soria Melguizo). Results were confirmed with posterior serogrouping with the Streptococcal Grouping Kit (Oxford, UK). The culture was considered negative after 48 hours of incubation with the absence of beta-haemolytic colonies.

The participating physicians collected the variables in a data registry notebook and reported age, sex, clinical symptoms (fever, sore throat, tender cervical nodes, absence of cough, abrupt onset), culture result, use of RADT or not, antibiotic or not, type of antibiotic, and evolution within the first month. Primary outcomes were the percentage of antibiotic prescription and the proportion of inappropriate antibiotic prescription. The latter included both patients without GABHS infection treated with antibiotics and those with GABHS infection in which antibiotic therapy was not given. Secondary outcomes were the type of antibiotics prescribed, the validity of the RADT, and full clinical recovery at the third week. The latter included patients without side effects, visits that required a change of treatment, or the presence of complications.

For calculating the sample size, it was considered that 276 patients were required in each arm to detect a reduction in antibiotic prescription from 85% in the control group to 75% in the intervention group with a power of 90% and a level of significance of 5% (two-sided), allowing 10% for losses in the follow-up visits.

Data were analysed in accordance with CONSORT guidelines. Descriptive statistics of the outcome measures were performed, as well as baseline characteristics and clinical measures, calculating means and standard deviations or percentages; χ2 tests were carried out to assess the impact of RADT on the percentage of antibiotic prescription and its inappropriateness in the intervention and control arms. Only P-values <0.05 were considered statistically significant.

RESULTS

Of the 80 physicians invited to participate, 19 declined (Figure 1). The number of cases included ranged from six to 10 per physician. During the period of study, 557 adults with acute pharyngitis and at least one Centor criterion were enrolled by 61 GPs. Of these, data for 543 were analysed (281 [51.7%] in the intervention group and 262 [48.3%] in the control group). Table 1 describes the demographic data and the clinical criteria according to the group assigned. No statistically significant differences were found in these variables in either group. Of the physicians assigned to RADT, these rapid tests were performed in 280 cases (99.6%), while rapid tests were performed in five cases (1.9%) in the control group. Antibiotics were prescribed in 291 cases (53.6%), with amoxicillin being the most frequently prescribed in 154 cases (52.9%), followed by penicillin in 58 (19.9%), amoxicillin plus clavulanic acid in 51 (17.5%), and macrolides in 20 cases (6.8%). Other antibiotics were prescribed in nine patients (3.1%). In seven cases, allergy to penicillin was reported.

Figure 1.

Figure 1

Trial design and number of patients in each arm receiving antibiotics.

Table 1.

Characteristics of patients by group

Characteristic Intervention group (n=281)a Control group (n = 262),a Total (n = 543)a P-value
Male 103(36.7) 99 (37.8) 202 (37.2) 0.404

Mean age, (SD) years 31.8(11.5) 31.5(11.4) 31.7(11.4) 0.688

Fever 199(70.8) 190(72.5) 389(71.6) 0.533

Tonsillar exudate 141 (50.2) 140(53.4) 281 (51.7) 0.379

Tender cervical lymph nodes 114(40.6) 106(40.5) 220 (40.5) 0.942

Absence of cough 211 (75.1) 195(74.4) 406 (74.8) 0.977

Abrupt onset 126(44.8) 109(41.6) 235 (43.3) 0.952

Number of Centor criteria 0.898
1 70 (24.9) 61 (23.3) 131 (24.1)
2 89 (31.7) 82 (31.3) 171 (31.5)
3 76 (27.0) 74 (28.2) 150 (27.6)
4 46 (16.4) 45 (17.2) 91 (16.8)
a

Values are n (%) unless otherwise stated. SD = standard deviation.

GPs allocated to the control group prescribed antibiotics in 168 cases out of a total of 262 (64.1%), significantly more than the physicians assigned to the intervention group (123 of 281 [43.8%]; P<0.001). The greater the number of Centor criteria presented by the patients, the more antibiotics were prescribed regardless of whether RADT was available, although antibiotic prescription was significantly greater among physicians assigned to the control group (P<0.001) (Table 2).

Table 2.

Prescription of antibiotics by group, according to number of Centor criteria

Number of Centor criteria Intervention group (N= 281), n(%) Control group (N= 262), n(%) Total (N = 543), n (%)
1 4(5.7) 20 (32.8) 24(18.3)
2 29 (32.6) 48(58.6) 77 (45.0)
3 53 (69.7) 57 (77.0) 110(73.3)
4 37 (80.4) 43 (95.6) 80 (87.9)
Total 123 (43.8) 168(64.1) 291 (53.6)

Cultures were performed in 526 patients with pharyngitis. Of these, the culture was positive for GABHS in 88 cases (16.7%). Among physicians assigned to the intervention group, the culture was positive for GABHS in 49 cases (18.1%), while it was positive in 39 patients (15.3%) in the control group, with no statistically significant differences observed between the two groups. The rapid test was positive in 60 cases (21.1%). In these cases, antibiotics were prescribed in 59 patients (98.3%). On the other hand, antibiotics were prescribed in 69 of the 225 patients in whom the test for GABHS was negative (30.7%). The greatest proportion of antibiotics prescribed in cases of negative RADT was observed among patients with four Centor criteria; thus antibiotics were prescribed in 21 out the 29 RADT-negative cases (72.4%). The other percentages of antibiotic prescription in cases that were RADT negative were 57.4%, 18.6%, and 5.8% in patients with three, two, and one Centor criteria respectively. As shown in Table 3, the sensitivity of RADT was 89.8%, with a specificity of 93.8%.

Table 3.

Validity of the rapid antigen detection test depending on the number of Centor criteria

Number of Centor criteria n %GABHS Sensitivity,% Specificity,% Positive predictive value,% Negative predictive value,%
1 73 0(-) - 95.9 - 95.9
2 87 13(14.9) 84.6 89.2 57.9 97.1
3 74 19 (25.7) 94.7 94.5 85.7 98.1
4 42 17 (40.5) 88.2 100.0 100.0 92.6
Total 276 49 (17.8) 89.8 93.8 75.9 97.7

GABHS = group A beta-haemolytic streptococcus.

Treatment was inappropriate in 226 cases (43%). Of these cases, antibiotic treatment was not necessary in 210, and in 16 more the culture was positive for GABHS and antibiotic treatment was not prescribed. The inappropriateness of the antibiotic treatment was significantly greater among physicians assigned to the control group (153 cases; 60%) than in the intervention group (73 cases; 26.9%; P<0.001). Likewise, the greater the number of Centor criteria presented by the patient, the greater the inappropriateness of prescription in both the control and the intervention groups (P<0.001) (Table 4).

Table 4.

Inappropriateness of antibiotic prescription by group, according to number of Centor criteria

Number of Centor criteria Intervention group (N = 271), n(%) Control group (N =255), n(%) Total (N = 526), n (%)
1 4(5.9) 24 (39.3) 28(21.7)
2 20 (23.3) 48(60.0) 68(41.0)
3 32 (43.2) 49 (69.0) 81 (55.9)
4 17 (39.5) 32 (74.4) 49 (57.0)
Total 73 (26.9) 153 (60.0) 226 (43.0)

With regard to the evolution of pharyngitis in 511 cases (94.1% of all the cases), full clinical recovery rate at the third week was present in 223 of the 274 patients treated with antibiotics (81.4%) and in 204 of the 237 (86.1%) not treated with antibiotics; the differences were not statistically significant. Side effects were slightly higher among patients treated with antibiotics (32 versus 18), with gastrointestinal side effects being the most frequent. Rash was reported in two cases treated with antibiotics. No complications were observed.

DISCUSSION

Summary

The use of RADTs as an aid to primary care physicians in deciding whether adults with acute pharyngitis should be treated with antibiotics is effective in significantly decreasing antibiotic prescription by more than 20%, and in reducing the inappropriateness of prescription by 33% in comparison with the group of physicians using only clinical criteria to guide prescription.

Strengths and limitations

The centres and practitioners participating in this study may have been more motivated than others and may have been more likely to follow current guidelines and follow better clinical practice. A potentially significant limitation is the Hawthorne effect, which may have introduced bias because GPs in the control group may have altered their habits of prescribing. To reduce this risk, GPs in the control group were specifically instructed to follow their usual care. Including a placebo RADT could have reduced this bias but would have been complicated in a study with these characteristics, and it was therefore decided not to do so. In any case, this aspect may have reduced the impact of the results obtained in relation to the optimisation of treatment of acute pharyngitis with RADT. Another limitation is the response rate achieved. Even though all the centres agreed to participate, a total of 19 physicians declined. Nonetheless, given the number of cases included in this study, the authors do not believe that this limitation affected the validity of the results obtained.

Another limitation is that all the cases with pharyngitis with at least one Centor criterion were considered. The guidelines currently available recommend the use of RADT in patients with at least two Centor criteria, not those with only one. However, this study was initiated in 2008 when no clear recommendations on the use of RADT were available in Spain. In this study the unit of randomisation was the centre not the physician to avoid contamination among physicians working in the same centre. It was considered that it may have not been appropriate to randomise individuals as patients who attend the same primary healthcare centre may be treated in the same way. None of the physicians included had previously used RADT, so the use of both the RADT technique and pharyngeal swab for microbiological testing were correctly explained beforehand.

Comparison with existing literature

Few studies have been performed in adults to date that give information on the impact of RADT on antibiotic prescription. McIsaac et al reported a 45% reduction in antibiotic prescription in adults using RADT compared with empirical treatment.24 Worrall et al reported a proportion of antibiotic prescription of 58% among physicians who did not use RADTs and 27% among those who did use this rapid test.20 Similarly, in another primary care study carried out in Switzerland, the use of RADT reduced antibiotic prescribing from 60% to 37%.23 Curiously, in recent studies carried out in paediatrics, in which the incidence of streptococcal infection is higher, greater reductions were observed, with percentages of antibiotic prescription among physicians assigned to RADT ranging from 22% to 28%.26,27

In the present trial, one intriguing question remains about the use of RADT in consulting offices. Even after using RADT, the antibiotic prescription rate exceeded 40%, which is much higher than the known community infection rate with GABHS. The most probable explanation is that physicians assigned to the intervention group did not trust the results of RADT, as more than 30% of the cases with negative results were prescribed antibiotics. This remained clear in the fact that more than 70% of the cases with four Centor criteria and a negative RADT result, and almost 60% with three criteria, received antibiotics. This is probably because physicians in Spain are used to prescribing antibiotic to patients with sore throat and are not used to using rapid tests. Nonetheless, before initiating the study all physicians were informed of the validity of the test and how to perform the technique correctly.

Over recent years, cases of bacteraemic infections caused by Fusobacterium nechrophorum have been reported in young patients, extending the cases of pharyngitis that need antibiotic therapy.28 This fact could also explain why so many antibiotics were prescribed with negative test results. This high percentage of antibiotic prescription has also been reported in other studies. In a 6-year retrospective study carried out in Sweden and published recently, negative RADT results were followed by antibiotic prescription in about 40% of cases.6 Similar results were found in a Swiss study, which showed that as many as 75% of patients presenting a negative test outcome received antibiotics.29 Thus, in countries in which rapid tests are still not used it is essential that all GPs are correctly informed of the benefits of this test and the low incidence of streptococcal infection in adults. Moreover, the validity of the test was shown mainly among patients with three or four Centor criteria, and thus, when the RADT result is negative, the physician can trust the result and act accordingly without prescribing an antibiotic. Furthermore, in adults it is necessary to discuss the need indicated by other physicians, mainly paediatricians, to confirm the negative results of the test with a culture, as a negative test discards infection by GABHS in practically all cases.

As expected, side effects were slightly higher among patients treated with antibiotics, with gastrointestinal side effects being most frequent. Of some concern was the finding that, when an antibiotic was used, it was likely to be amoxicillin. This antibiotic, together with the combination of amoxicillin plus clavulanic acid, corresponds to broad-spectrum beta-lactams, which should be avoided in this infection in which it is known that GABHS is uniformly susceptible to penicillin V. In the present study, only 20% of the antibiotics prescribed corresponded to this antibiotic. Curiously, 20 macrolides were prescribed despite only seven allergies to penicillin being reported. Moreover, the percentages of resistance of GABHS to macrolides are already greater than 15% of the cases in Spain.30

Another finding of note was the specificity recorded by the RADT used in this study, which was 93.8% when most studies report this to be more than 95%. On the other hand, the sensitivity of the test, at almost 90%, was found to be within the margin described in other studies.22 The inclusion of many physicians from 20 different centres may explain the lower specificity. Nonetheless, the authors do not believe that these results should discourage primary care physicians from using RADT in their offices. The main advantage of RADT over throat swab cultures is that the results can be available in only 5 minutes. According to the present results, RADT should not be used if signs of viral infection exist, that is, in those with fewer than two Centor criteria and the use of Centor criteria should only be recommended for select patients who might gain from antibiotic treatment and the use of rapid testing before receiving an antibiotic prescription.

Implications for research and practice

Based on the results obtained in this study, it would be interesting to carry out qualitative research to investigate the reasons why physicians prescribe antibiotic despite negative test results. This will enable a better approach to this problem, which, according to the results of the present study, is not marginal. The clinical trial could be repeated in other areas to determine whether or not these results are replicated.

This pragmatic randomised clinical trial found that the use of the RADT in primary care offices was associated with a significant reduction in the prescription of antibiotics among adults with a clinical diagnosis of acute pharyngitis. However, the reduction in antibiotic prescription was expected to be much higher, and this might be mainly explained by the fact that GPs were not used to using these tests and, more specifically, may still be uncertain as to the validity of their results.

Acknowledgments

The authors would like to thank all the primary care physicians who participated in this study.

Funding

This clinical trial (registration number ISRCTN23587778) was funded by the Fondo de Investigaciones Sanitarias, the University and Innovation Department of Spain (reference number: PI061782), and by the Catalan Society of Family Medicine.

Ethical approval

The trial was approved by the Ethical and Clinical Research Committee of the Jordi Gol Institute of Research in Primary Health Care (Certificate number: P06/03).

Competing interests

The Rapid Test Device OSOM StrepA of Genzyme was kindly provided by Leti. All the authors declare they have received no honoraria from the Leti Laboratory for undertaking this study. Carl Llor declares having received tests free of charge from Leti for investigational studies. In the last 3 years Leti has covered the travel and accommodation costs for seeking the inclusion of physicians in a control group in the Happy Audit study in Murcia. Leti also covered the accommodation costs during an international congress on respiratory disease in primary care within the last year. The authors have declared no other competing interests.

Discuss this article

Contribute and read comments about this article on the Discussion Forum: http://www.rcgp.org.uk/bjgp-discuss

REFERENCES

  • 1.Neuner JM, Hamel MB, Phillips RS, et al. Diagnosis and management of adults with pharyngitis. A cost-effectiveness analysis. Ann Intern Med. 2003;139(2):113–122. doi: 10.7326/0003-4819-139-2-200307150-00011. [DOI] [PubMed] [Google Scholar]
  • 2.Llor C, Cots JM, Bjerrum L, et al. Antibiotic prescribing in respiratory tract infections and predictive factors for their use. Aten Primaria. 2010;42(1):28–35. doi: 10.1016/j.aprim.2009.04.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Patterson CA, Mackeson JM, Weekes LM. Antibiotic prescribing for upper respiratory tract infections in primary care. Commun Dis Intell. 2003;27(suppl):S39–41. [PubMed] [Google Scholar]
  • 4.Demelker RA, Kuyvenhovven MM. Management of upper respiratory tract infections in Dutch general practice. Br J Gen Pract. 1991;41(353):507–510. [PMC free article] [PubMed] [Google Scholar]
  • 5.Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections and bronchitis, by ambulatory care physicians. JAMA. 1997;278(11):901–904. [PubMed] [Google Scholar]
  • 6.Neumark T, Brudin L, Mölstad S. Use of rapid diagnostic tests and choice of antibiotics in respiratory tract infections in primary healthcare — a 6-y follow-up study. Scand J Infect Dis. 2010;42(2):90–96. doi: 10.3109/00365540903352932. [DOI] [PubMed] [Google Scholar]
  • 7.Linder JA, Stafford RS. Antibiotic treatment of adults with sore throat by community primary care physicians: a national survey, 1989–1999. JAMA. 2001;286(10):1181–1186. doi: 10.1001/jama.286.10.1181. [DOI] [PubMed] [Google Scholar]
  • 8.Cooper RJ, Hoffman JR, Bartlett JG, et al. Prevention Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med. 2001;134(6):509–517. doi: 10.7326/0003-4819-134-6-200103200-00019. [DOI] [PubMed] [Google Scholar]
  • 9.Pichichero ME, Disney FA, Talpey WB, et al. Adverse and beneficial effects of immediate treatment for group A beta-hemolytic streptococcal pharyngitis with penicillin. Pediatr Infect Dis J. 1987;6(7):635–643. doi: 10.1097/00006454-198707000-00004. [DOI] [PubMed] [Google Scholar]
  • 10.NICE Short Clinical Guidelines Technical Team. Prescribing of antibiotics for self-limiting respiratory tract infections in adults and children in primary care. London: National Institute for Health and Clinical Excellence; 2008. Respiratory tract infections — antibiotic prescribing. [PubMed] [Google Scholar]
  • 11.Del Mar CB, Glasziou PP, Spinks AB. Antibiotics for sore throat. Cochrane Database Syst Rev. 2006;(4):CD000023. doi: 10.1002/14651858.CD000023.pub3. [DOI] [PubMed] [Google Scholar]
  • 12.Touw-Otten F, Johansen KS. Diagnosis, antibiotic treatment and outcome of tonsillitis: report of a WHO office for 17 European countries. Fam Pract. 1992;9(3):255–262. doi: 10.1093/fampra/9.3.255. [DOI] [PubMed] [Google Scholar]
  • 13.Little P, Williamson I. Sore throat management in general practice. Fam Pract. 1996;13(3):317–321. doi: 10.1093/fampra/13.3.317. [DOI] [PubMed] [Google Scholar]
  • 14.Petersen I, Johnson AM, Islam A, et al. Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK General Practice Research Database. BMJ. 2007;335(7627):982. doi: 10.1136/bmj.39345.405243.BE. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Pichichero ME. Group A streptococcal tonsillopharyngitis: cost-effective diagnosis and treatment. Ann Emerg Med. 1995;25(3):404–406. doi: 10.1016/s0196-0644(95)70300-4. [DOI] [PubMed] [Google Scholar]
  • 16.Centor RM, Whiterspoon JM, Dalton HP, et al. The diagnosis of strep throat in adults in the emergency room. Med Decis Making. 1981;1(3):239–246. doi: 10.1177/0272989X8100100304. [DOI] [PubMed] [Google Scholar]
  • 17.Gerber MA, Shulman ST. Rapid diagnosis of pharyngitis caused by group A streptococci. Clin Microbiol Rev. 2004;17(3):571–580. doi: 10.1128/CMR.17.3.571-580.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Gerber MA. Comparison of throat cultures and rapid streptococcal tests for diagnosis of streptococcal pharyngitis. Pediatr Infect Dis J. 1989;8(11):820–824. doi: 10.1097/00006454-198911000-00032. [DOI] [PubMed] [Google Scholar]
  • 19.McIsaac WJ, Goel V, To T, et al. Effect on antibiotic prescribing of repeated clinical prompts to use a sore throat score: lessons from a failed community intervention study. J Fam Pract. 2002;51(4):339–344. [PubMed] [Google Scholar]
  • 20.Worrall G, Hutchinson J, Sherman G, Griffiths J. Diagnosing streptococcal sore throat in adults. Randomized controlled trial of in-office aids. Can Fam Physician. 2007;53(4):667–671. [PMC free article] [PubMed] [Google Scholar]
  • 21.Bisno AL, Gerber MA, Gwaltney JM, et al. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis. 2002;35(2):113–125. doi: 10.1086/340949. [DOI] [PubMed] [Google Scholar]
  • 22.Lasseter GM, McNulty CA, Richard Hobbs F, et al. on behalf of the PRISM Investigators. In vitro evaluation of five rapid antigen detection tests for group A beta-haemolytic streptococcal sore throat infections. Fam Pract. 2009;26(6):437–444. doi: 10.1093/fampra/cmp054. [DOI] [PubMed] [Google Scholar]
  • 23.Humair JP, Revaz SA, Bovier P, Stalder H. Management of acute pharyngitis in adults: reliability of rapid streptococcal tests and clinical findings. Arch Intern Med. 2006;166(6):640–644. doi: 10.1001/archinte.166.6.640. [DOI] [PubMed] [Google Scholar]
  • 24.McIsaac WJ, Kellner JD, Aufricht P, et al. Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA. 2004;291(13):1587–1595. doi: 10.1001/jama.291.13.1587. [DOI] [PubMed] [Google Scholar]
  • 25.Madurell J, Balagué M, Gómez M, et al. Impact of rapid antigen detection testing on antibiotic prescription in acute pharyngitis in adults. FARINGOCAT study: a multicentric randomized controlled trial. BMC Fam Pract. 2010;11(1):25. doi: 10.1186/1471-2296-11-25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Maltezou HC, Tasgris V, Antoniadou A, et al. Evaluation of a rapid antigen detection test in the diagnosis of streptococcal pharyngitis in children and its impact on antibiotic prescription. J Antimicrob Chemother. 2008;62(6):1407–1412. doi: 10.1093/jac/dkn376. [DOI] [PubMed] [Google Scholar]
  • 27.Ayanruoh S, Waseem M, Quee F, et al. Impact of rapid streptococcal test on antibiotic use in a pediatric emergency department. Pediatr Emerg Care. 2009;25(11):748–750. doi: 10.1097/PEC.0b013e3181bec88c. [DOI] [PubMed] [Google Scholar]
  • 28.Centor RM. Expand the pharyngitis paradigm for adolescents and young adults. Ann Intern Med. 2009;151(11):812–815. doi: 10.7326/0003-4819-151-11-200912010-00011. [DOI] [PubMed] [Google Scholar]
  • 29.Stürchler MS, Vuille P, Semp E, et al. [Diagnosis and antibiotic therapy of infections in outpatients] Schweiz Med Wochenschr. 2000;130(41):1437–1446. [PubMed] [Google Scholar]
  • 30.Pérez-Trallero E, Martín-Herrero JE, Mazón A, et al. Antimicrobial resistance among respiratory pathogens in Spalatest data and changes over 11 years (1996–1997 to 2006–2007) Antimicrob Agents Chemother. 2010;54(7):2953–2959. doi: 10.1128/AAC.01548-09. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of General Practice are provided here courtesy of Royal College of General Practitioners

RESOURCES